1 / 7

Global Smoking Cessation and Nicotine De-Addiction Products

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Enquire About Report: http://www.researchbeam.com/smoking-cessation-nicotine-de-addiction-products-market/enquire-about-report

BretSZavala
Download Presentation

Global Smoking Cessation and Nicotine De-Addiction Products

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESEARCH BEAM SIZE FORECAST RESEARCH DEMAND Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) 2013-2020 AND SIZE MARKET AND & RESEARCH RESEARCH RESEARCH MARKET SIZE FORECAST RESEARCH DEMAND AND SIZE MARKET AND & RESEARCH RESEARCH • TELEPHONE: +1 (855) 711-1555E-MAIL:sales@researchbeam.com FORECAST

  2. ReportOverview Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts can be better treated with smoking cessation products. The global market for smoking cessation and nicotine de-addiction products encompasses nicotine replacement therapy (NRT), electronic cigarettes and therapeutic medication such as anti-depressants and nicotine receptor agonists. Government is emphasizing strict regulations to control the nicotine and cigarette addiction due to its toxic effects on cardiac and respiratory systems. The government policies in relation to smoking cessation include smoking prohibition in public places, high taxes on tobacco products and support for smoking discontinuation therapies. Hence, global market for smoking cessation and nicotine de-addiction products is expected to witness high CAGR during the forecast period. Johnson & Johnson, Pfizer, GlaxoSmithKline, Takeda Pharmaceuticals, Revolymer PLC and Cipla are some of the key leaders of this market.

  3. ReportOverview NJOY and VMR products are the key players for e-cigarettes market. GlaxoSmithKline and Pfizer are the leaders in drug therapy products market for smoking cessation and nicotine de-addiction. The global market for smoking cessation and nicotine de-addiction products is segmented based on product types and geography. Based on type of products, the global market is segmented as Nicotine Replacement Therapy Products, Drug Therapy, Nicotine Sublingual Tablets, Nicotine Inhalers and E-cigarettes. Electronic cigarettes (E-cigarettes) dominate the overall market for smoking cessation and nicotine de-addiction. The largest share for E-cigarettes is shared by North America and Europe. Nicotine Gums and Nicotine Transdermal Patches dominate the global market for Nicotine Replacement Therapy Products. Geographically, global market for smoking cessation and nicotine de-addiction products is segmented into North America, Europe, Asia-Pacific and LAMEA. North America rules the global market for smoking cessation and nicotine de-addiction products; whereas, Asia-Pacific is predicted as profitable market in the near future due increased health awareness and government support programs.

  4. ReportOverview • KEY BENEFITS • This report offers the following benefits in particular: • In-depth coverage of drivers, restraints and opportunities within global market for smoking cessation and nicotine de-addiction products would help professionals to better understand market behavior • Porter’s Five Forces analysis examines the competitive structure of the global market for smoking cessation and nicotine de-addiction products and would assist market strategists in their respective decision making process • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for smoking cessation and nicotine de-addiction products • Deep insights to key development and regulatory framework of global market for smoking cessation and nicotine de-addiction products would be informative for professionals in corporate sector

  5. ReportOverview • KEY MARKET SEGMENTS • The global market for smoking cessation and nicotine de-addiction products is segmented into two major categories such as, Product type and geography. • MARKET BY PRODUCT TYPE • Nicotine Replacement Therapy Products • Nicotine Lozenges • Nicotine Gums • Nicotine Sprays • Nicotine Transdermal Patches • Drug Therapy • Zyban (Bupropion) • Chantix (varenicline) • Enquire About Report: • http://www.researchbeam.com/smoking-cessation-nicotine-de-addiction-products-market/enquire-about-report

  6. Similar Market Reports Taiwan Liposome Company, Ltd. (4152) - Pharmaceuticals & Healthcare - Deals and Alliances Profile July  2014 Summary Taiwan Liposome Company, Ltd. (TLC) is a bio pharmaceutical company. The company undertakes the research, development and commercialization of pharmaceutical products by utilizing its proprietary drug delivery technologies. Global Dermatological Drugs Market 2014-2018 March  2014 TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. OpexaTherapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile April  2014 Summary Opexa Therapeutics, Inc. (Opexa) is a biotechnology company. The company develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, diabetes and heart failure.

  7. Contact Visit us at: http://www.researchbeam.com/smoking-cessation-nicotine-de-addiction-products-market • TELEPHONE: +1 (855) 711-1555E-MAIL:help@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related